28224 Federal Register / Vol. 61, No. 108 / Tuesday, June 4, 1996 / Notices

limitations imposed by the review and

funding cycle.

(Catalog of Federal Domestic Assistance

Program No. 93.121, Dental Research

Institute; National Institutes of Health, HHS)

Dated: May 29, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–13960 Filed 6–3–96; 8:45 am]

BILLING CODE 4140–01–M

National Institute of Dental Research;

Notice of a Meeting of the National

Advisory Dental Research Council

Pursuant to Pub. L. 92–463, notice is

hereby given of a meeting of the

National Advisory Dental Research

Council, National Institute of Dental

Research, On June 11–12, 1996. The

meeting of the full Council will be open

to the public on June 11 from 8:30 a.m.

to recess, Conference Room 10, Sixth

Floor, Building 31, National Institutes of

Health, Bethesda, Maryland, for general

discussion and program presentations.

Attendance by the public will be limited

to space available.

In accordance with the provisions set

forth in secs. 552b(c)(4) and 552b(c)(6),

Title 5, U.S.C. and sec. 10(d) of Pub. L.

92–463, the meeting of the Council will

be closed to the public on June 12, 8:30

a.m. to adjournment, for the review,

discussion and evaluation of individual

grant applications. These applications

and information concerning individuals

associated with the discussions could

reveal confidential trade secrets or

commercial property such as patentable

material, and personal applications and

reports, the disclosure of which would

constitute a clearly unwarranted

invasion of personal privacy.

Dr. Dushanka V. Kleinman, Executive

Secretary, National Advisory Dental

Research Council, and Deputy Director,

National Institute of Dental Research,

National Institutes of Health, Building

31, Room 2C39, Bethesda, Maryland

20892, (telephone (301) 496–9469) will

furnish a roster of committee members,

a summary of the meeting, and other

information pertaining to the meeting.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

contact the Executive Secretary listed

above in advance of the meeting.

This notice is being published less

than 15 days prior to the meeting due

to the urgent need to meet timing

limitations imposed by the review and

funding cycle.

(Catalog of Federal Domestic Assistance

Program No. 93.121, Oral Diseases and

Disorders Research)

Dated: May 29, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–13961 Filed 6–3–96; 8:45 am]

BILLING CODE 4140–01–M

National Institutes of Health; Division

of Research Grants; Notice of Closed

Meetings

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following Division

of Research Grants Special Emphasis

Panel (SEP) meetings:

Purpose/Agenda: To review

individual grant applications.

Name of SEP: Chemistry and Related

Sciences.

Date: June 14, 1996.

Time: 5:00 p.m.

Place: Holiday Inn, Chevy Chase, MD.

Contact Person: Dr. Nancy

Lamontagne, Scientific Review

Administrator, 6701 Rockledge Drive,

4170, Bethesda, Maryland 20892, (301)

435–1726.

This notice is being published less

than 15 days prior to the above meetings

due to the urgent need to meet timing

limitations imposed by the grant review

and funding cycle.

Name of SEP: Behavioral and

Neurosciences.

Date: June 25, 1996.

Time: 9:00 a.m.

Place: Radisson Barcelo Hotel,

Washington, DC.

Contact Person: Dr. Joseph Kimm,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5178, Bethesda,

Maryland 20982, (301) 435–1249.

Name of SEP: Behavioral and

Neurosciences.

Date: July 8–10, 1996.

Time: 8:30 a.m.

Place: Ramada Inn, Rockville, MD.

Contact Person: Dr. Joseph Marwah,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5188, Bethesda,

Maryland 20982 (301) 435–1253.

Name of SEP: Behavioral and

Neurosciences.

Date: July 9, 1996.

Time: 9:30 a.m.

Place: Holiday Inn, Chevy Chase, MD.

Contact Person: Dr. Herman

Teitelbaum, Scientific Review

Administrator, 6701 Rockledge Drive,

Room 5190, Bethesda, Maryland 20982,

(301) 435–1254.

Name of SEP: Biological and

Physiological Sciences.

Date: July 9, 1996.

Time: 8:00 a.m.

Place: Doubletree Hotel, Rockville,

MD.

Contact Person: Dr. Harish Chopra,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5112, Bethesda,

Maryland 20892, (301) 435–1169.

Name of SEP: Biological and

Physiological Sciences.

Date: July 11–12, 1996.

Time: 8:00 a.m.

Place: American Inn, Bethesda, MD.

Contact Person: Dr. Nicholas

Mazarella, Scientific Review

Administrator, 6701 Rockledge Drive,

Room 5128, Bethesda, Maryland 20892,

(301) 435–1018.

Name of SEP: Chemistry and Related

Sciences.

Date: July 12, 1996.

Time: 8:30 a.m.

Place: Hyatt Arlington, Arlington, VA.

Contact Person: Dr. Alex Liacouras,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5154, Bethesda,

Maryland 20892, (301) 435–1740.

Name of SEP: Chemistry and Related

Sciences.

Date: July 17–18, 1996.

Time: 8:00 a.m.

Place: Holiday Inn, Chevy Chase, MD.

Contact Person: Dr. Donald

Schneider, Scientific Review

Administrator, 6701 Rockledge Drive,

Room 5104, Bethesda, Maryland 20892,

(301) 435–1165.

Name of SEP: Multidisciplinary

Sciences.

Date: July 24, 1996.

Time: 10:00 a.m.

Place: Georgetown Holiday Inn,

Washington, DC.

Contact Person: Dr. Gerald Becker,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5114, Bethesda,

Maryland 20892, (301) 435–1750.

Name of SEP: Biological and

Physiological Sciences.

Date: October 23–25, 1996.

Time: 8:30 a.m.

Place: Holiday Inn, Chevy Chase, MD.

Contact Person: Dr. Lynwood Jones,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4192, Bethesda,

Maryland 20892, (301) 435–1153.

Purpose/Agenda: To review Small

Business Innovation Research.

Name of SEP: Microbiological and

Immunological Sciences.

Date: June 27–28, 1996.

Time: 8:30 a.m.

Place: Holiday Inn, Chevy Chase, MD.

Contact Person: Dr. Marcel Pons,

Scientific Review Administrator, 6701

Rockledge Drive, Room 4196, Bethesda,

Maryland 20892, (301) 435–1217.

Name of SEP: Multidisciplinary

Sciences.

Date: July 8, 1996.
Federal Register / Vol. 61, No. 108 / Tuesday, June 4, 1996 / Notices 28225

Time: 8:00 a.m.

Place: Doubletree Hotel, Rockville,

MD.

Contact Person: Dr. Bill Bunnag,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5212, Bethesda,

Maryland 20892, (301) 435–1177.

Name of SEP: Multidisciplinary

Sciences.

Date: July 8–10, 1996.

Time: 8:00 a.m.

Place: Ramada Inn, Rockville, MD.

Contact Person: Dr. Dharam Dhindsa,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5206, Bethesda,

Maryland 20892, (301) 435–1174.

Name of SEP: Biological and

Physiological Sciences.

Date: July 8, 1996.

Time: 8:00 a.m

Place: Doubletree Hotel, Rockville,

MD.

Contact Person: Dr. Harish Chopra,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5112, Bethesda,

Maryland 20892, (301) 435–1169.

Name of SEP: Multidisciplinary

Sciences.

Date: July 10, 1996.

Time: 8:00 a.m.

Place: Doubletree Hotel, Rockville,

MD.

Contact Person: Dr. Bill Bunnag,

Scientific Review Administrator, 6701

Rockledge Drive, Room 5212, Bethesda,

Maryland 20892, (301) 435–1177.

Name of SEP: Biological and

Physiological Sciences.

Date: August 1, 1996.

Time: 8:30 a.m.

Place: Doubletree Hotel, Rockville,

MD.

Contact Person: Dr. Abubakar Shaikh,

Scientific Review Administrator, 6701

Rockledge Drive, Room 6166, Bethesda,

Maryland 20892, (301) 435–1042.

The meetings will be closed in

accordance with the provisions set forth

in secs. 552b(c)(4) and 552b(c)(6), Title

5, U.S.C. Applications and/or proposals

and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material

and personal information concerning

individuals associated with the

applications and/or proposals, the

disclosure of which would constitute a

clearly unwarranted invasion of

personal privacy.

(Catalog of Federal Domestic Assistance

Program Nos. 93.306, 93.333, 93.337, 93.393–

93.396, 93.837–93.844, 93.846–93.878,

93.892, 93.893, National Institutes of Health,

HHS)

Dated: May 29, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–13958 Filed 6–3–96; 8:45 am]

BILLING CODE 41140–01–M

Substance Abuse and Mental Health

Services Administration

Current List of Laboratories Which

Meet Minimum Standards To Engage in

Urine Drug Testing for Federal

Agencies, and Laboratories That Have

Withdrawn From the Program

AGENCY: Substance Abuse and Mental

Health Services Administration, HHS

(Formerly: National Institute on Drug

Abuse, ADAMHA, HHS).

ACTION: Notice.

SUMMARY: The Department of Health and

Human Services notifies Federal

agencies of the laboratories currently

certified to meet standards of Subpart C

of Mandatory Guidelines for Federal

Workplace Drug Testing Programs (59

FR 29916, 29925). A similar notice

listing all currently certified laboratories

will be published during the first week

of each month, and updated to include

laboratories which subsequently apply

for and complete the certification

process. If any listed laboratory’s

certification is totally suspended or

revoked, the laboratory will be omitted

from updated lists until such time as it

is restored to full certification under the

Guidelines.

If any laboratory has withdrawn from

the National Laboratory Certification

Program during the past month, it will

be identified as such at the end of the

current list of certified laboratories, and

will be omitted from the monthly listing

thereafter.

FOR FURTHER INFORMATION CONTACT: Mrs.

Giselle Hersh, Division of Workplace

Programs, Room 13A–54, 5600 Fishers

Lane, Rockville, Maryland 20857; Tel.:

(301) 443–6014.

SUPPLEMENTARY INFORMATION:

Mandatory Guidelines for Federal

Workplace Drug Testing were developed

in accordance with Executive Order

12564 and section 503 of Pub. L. 100–

71. Subpart C of the Guidelines,

‘‘Certification of Laboratories Engaged

in Urine Drug Testing for Federal

Agencies,’’ sets strict standards which

laboratories must meet in order to

conduct urine drug testing for Federal

agencies. To become certified an

applicant laboratory must undergo three

rounds of performance testing plus an

on-site inspection. To maintain that

certification a laboratory must

participate in a quarterly performance

testing program plus periodic, on-site

inspections.

Laboratories which claim to be in the

applicant stage of certification are not to

be considered as meeting the minimum

requirements expressed in the HHS

Guidelines. A laboratory must have its

letter of certification from SAMHSA,

HHS (formerly: HHS/NIDA) which

attests that it has met minimum

standards.

In accordance with Subpart C of the

Guidelines, the following laboratories

meet the minimum standards set forth

in the Guidelines:

Aegis Analytical Laboratories, Inc., 624

Grassmere Park Rd., Suite 21, Nashville,

TN 37211, 615–331–5300

Alabama Reference Laboratories, Inc., 543

South Hull St., Montgomery, AL 36103,

800–541–4931/205–263–5745

American Medical Laboratories, Inc., 14225

Newbrook Dr., Chantilly, VA 22021, 703–

802–6900

Associated Pathologists Laboratories, Inc.,

4230 South Burnham Ave., Suite 250, Las

Vegas, NV 89119–5412, 702–733–7866

Associated Regional and University

Pathologists, Inc. (ARUP), 500 Chipeta

Way, Salt Lake City, UT 84108, 801–583–

2787

Baptist Medical Center—Toxicology

Laboratory, 9601 I–630, Exit 7, Little Rock,

AR 72205–7299, 501–227–2783 (formerly:

Forensic Toxicology Laboratory Baptist

Medical Center)

Bayshore Clinical Laboratory, 4555 W.

Schroeder Dr., Brown Deer, WI 53223,

414–355–4444/800–877–7016

Cedars Medical Center, Department of

Pathology, 1400 Northwest 12th Ave.,

Miami, FL 33136, 305–325–5810

Centinela Hospital Airport Toxicology

Laboratory, 9601 S. Sepulveda Blvd., Los

Angeles, CA 90045, 310–215–6020

Clinical Reference Lab, 11850 West 85th St.,

Lenexa, KS 66214, 800–445–6917

CompuChem Laboratories, Inc., 1904

Alexander Drive, Research Triangle Park,

NC 27709, 919–549–8263/800–833–3984

(Formerly: CompuChem Laboratories, Inc.,

A Subsidiary of Roche Biomedical

Laboratory, Roche CompuChem

Laboratories, Inc., A Member of the Roche

Group)

CORNING Clinical Laboratories, 4771 Regent

Blvd., Irving, TX 75063, 800–526–0947

(formerly: Damon Clinical Laboratories,

Damon/MetPath)

CORNING Clinical Laboratories, 875

Greentree Rd., 4 Parkway Ctr., Pittsburgh,

PA 15220–3610, 800–284–7515 (formerly:

Med-Chek Laboratories, Inc., Med-Chek/

Damon, MetPath Laboratories)

CORNING Clinical Laboratories, 24451

Telegraph Rd., Southfield, MI 48034, 800–

444–0106 ext. 650 (formerly: HealthCare/

Preferred Laboratories, HealthCare/

MetPath)

CORNING Clinical Laboratories Inc., 1355

Mittel Blvd., Wood Dale, IL 60191, 708–

595–3888 (formerly: MetPath, Inc.,

CORNING MetPath Clinical Laboratories)

CORNING Clinical Laboratories, South

Central Divison, 2320 Schuetz Rd., St.

Louis, MO 63146, 800–288–7293 (formerly:

Metropolitan Reference Laboratories, Inc.)

CORNING Clinical Laboratory, One Malcolm

Ave., Teterboro, NJ 07608, 201–393–5000

(formerly: MetPath, Inc., CORNING

MetPath Clinical Laboratories)

CORNING National Center for Forensic

Science, 1901 Sulphur Spring Rd.,